pentoxifylline d6

Ipenoxazone HCl is a glutamate receptor antagonist potentially for the treatment of Alzheimer's disease.

Pentoxifylline-d6 is intended for use as an internal standard for the quantification of pentoxifylline by GC- or LC-MS. Pentoxifylline is a hemorrheologic agent. It increases the deformability of washed isolated human erythrocytes when used at a concentration of 100 µM. Pentoxifylline (1, 2, and 3 mM) inhibits ADP-induced platelet aggregation in isolated human whole blood. It inhibits thrombus formation induced by ADP in a hamster cheek pouch model when administered at doses of 5, 10, and 20 mg kg. Formulations containing pentoxifylline have been used in the treatment of intermittent claudication.

Hydroxy Pentoxifylline-d6 是 Hydroxy Pentoxifylline 的氘代化合物。Hydroxy Pentoxifylline 的 CAS 号为 6493-06-7。(±)-Lisofylline 是一种对映异构体特异性、烷基取代的甲基黄嘌呤，在下调白细胞活化方面具有特异性和有效的活性。它是一种抗炎剂。